U.S. Physical Therapy, Inc. Common Stock (NY:USPH)

88.53 -0.20 (-0.23%)

Official Closing Price Updated: 7:00 PM EDT, Oct 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about U.S. Physical Therapy, Inc. Common Stock

< Previous 1 2 3 4 5 Next >

3 Profitable Stocks We Find Risky

October 13, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

Why Concentra’s Quiet Healthcare Business Keeps Winning ↗

October 02, 2026

Concentra's Q2 revenue and profit beat estimates, and all eight analysts rate it a Buy, but a leadership transition and a 75% stock rally raise valuation questions.

Via MarketBeat

3 Cash-Producing Stocks with Questionable Fundamentals

September 30, 2026

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Via StockStory

U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement ↗

August 27, 2026

U.S. Physical Therapy (NYSE:USPH) is pursuing growth through clinic openings, acquisitions and a newer hospital-alliance strategy that Chief Executive Officer Chris Reading said could expand patient...

Via MarketBeat

U.S. Physical Therapy (NYSE:USPH) Misses on EPS, Reaffirms Full-Year Guidance ↗

August 05, 2026

Via Chartmill

U.S. Physical Therapy Inc. (NYSE:USPH) Shares Dip 4.2% on Q1 Earnings Miss Despite Record Revenue ↗

May 06, 2026

Via Chartmill

Topics Earnings

2 Small-Cap Stocks with Promising Prospects and 1 We Avoid

August 24, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

Via StockStory

Topics Electric Vehicles

Outpatient & Specialty Care Stocks Q2 Teardown: U.S. Physical Therapy (NYSE:USPH) Vs The Rest

August 18, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at U.S. Physical Therapy (NYSE:U...

Via StockStory

Topics Artificial Intelligence

USPH (USPH) Q2 2026 Earnings Call Transcript ↗

August 13, 2026

Record visit volumes offset by employee healthcare cost pressures in latest quarter.

Via The Motley Fool

Topics Earnings

1 Russell 2000 Stock Worth Investigating and 2 We Brush Off

August 10, 2026

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...

Via StockStory

U.S. Physical Therapy Q2 Earnings Call Highlights ↗

August 09, 2026

U.S. Physical Therapy (NYSE:USPH) reported second-quarter 2026 revenue growth supported by higher patient volumes, improved reimbursement rates and the early rollout of hospital-affiliation agreements,...

Via MarketBeat

Topics Earnings

Why U.S. Physical Therapy (USPH) Shares Are Trading Lower Today

August 06, 2026

What Happened? Shares of outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) fell 2.1% in the afternoon session after the company reported...

Via StockStory

Topics Earnings

Earnings To Watch: U.S. Physical Therapy (USPH) Reports Q2 Results Tomorrow

August 03, 2026

Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) will be reporting earnings this Wednesday after the bell. Here’s what to look for. U.S...

Via StockStory

3 Healthcare Stocks We Find Risky

July 30, 2026

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be...

Via StockStory

1 Profitable Stock Worth Your Attention and 2 We Avoid

July 16, 2026

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...

Via StockStory

Outpatient & Specialty Care Stocks Q1 Highlights: U.S. Physical Therapy (NYSE:USPH)

July 12, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at U.S. Physical Therapy (NYSE:U...

Via StockStory

Topics Artificial Intelligence

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

June 19, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

1 Cash-Producing Stock Worth Investigating and 2 We Turn Down

June 17, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

3 Reasons USPH is Risky and 1 Stock to Buy Instead

May 19, 2026

U.S. Physical Therapy currently trades at $65.04 per share and has shown little upside over the past six months, posting a small loss of 4.3%. The stock also...

Via StockStory

Topics Supply Chain

Stocks making big moves yesterday: Helios, DraftKings, CACI, U.S. Physical Therapy, and Ulta

May 13, 2026

Check out the companies making headlines yesterday: Helios (NYSE:HLIO): Motion control and electronic systems manufacturer Helios Technologies (NYSE:HLIO) ro...

Via StockStory

Topics World Trade

U.S. Physical Therapy’s Q1 Earnings Call: Our Top 5 Analyst Questions

May 13, 2026

U.S. Physical Therapy’s first quarter results were met with a sharp negative market reaction, reflecting investor concerns over margin compression and profit...

Via StockStory

Topics Earnings

U.S. Physical Therapy (USPH) Stock Is Up, What You Need To Know

May 12, 2026

What Happened? Shares of outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) jumped 4.4% in the afternoon session after the stock continue...

Via StockStory

Topics Artificial Intelligence

USPH Q1 Deep Dive: Margin Pressures and Growth Initiatives Amid Volume Growth

May 07, 2026

Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.9% year on year t...

Via StockStory

USPH Q1 2026 Earnings Call Transcript ↗

May 07, 2026

USPH Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

U.S. Physical Therapy’s (NYSE:USPH) Q1 CY2026 Earnings Results: Revenue In Line With Expectations

May 06, 2026

Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) met Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.9% year on year t...

Via StockStory

U.S. Physical Therapy (USPH) Q1 Earnings: What To Expect

May 04, 2026

Outpatient physical therapy provider U.S. Physical Therapy (NYSE:USPH) will be reporting earnings this Wednesday after market close. Here’s what to look for....

Via StockStory

Topics Artificial Intelligence

3 Cash-Producing Stocks Walking a Fine Line

April 24, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...

Via StockStory

3 of Wall Street’s Favorite Stocks with Open Questions

April 17, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

Topics Supply Chain

1 Healthcare Stock on Our Watchlist and 2 We Avoid

April 09, 2026

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...

Via StockStory

3 Reasons to Sell USPH and 1 Stock to Buy Instead

March 30, 2026

Although the S&P 500 is down 3.2% over the past six months, U.S. Physical Therapy’s stock price has fallen further to $74.73, losing shareholders 12% of thei...

Via StockStory

Topics Stocks Supply Chain

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.